The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 1, 2003, Pages 129-137

  Wallace, Melisa J ^b   Blair, Robert E ^a   Falenski, Katherine W ^b   Martin, Billy R ^b   DeLorenzo, Robert J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4,5 DIHYDRO 2 METHYL 4 (4 MORPHOLINYLMETHYL) 1 (1 NAPHTHALENYLCARBONYL) 6H PYRROLO[3,2,1 I,J]QUINOLIN 6 ONE; ANTICONVULSIVE AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABIS; PHENOBARBITAL; PHENYTOIN; PILOCARPINE; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; EPILEPTIC STATE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY; WESTERN BLOTTING;

ANIMALS; ANTICONVULSANTS; ARACHIDONIC ACIDS; CANNABINOIDS; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; GLYCERIDES; HIPPOCAMPUS; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SEIZURES;

EID: 0141742514     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.051920     Document Type: Article

References (40)

1. 1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci Lett 309:197-201.
2. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, and Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (Lond) 404:84-87.
3. 9-tetrahydrocannabinol and morphine. J Pharmacol Exp Ther 297:121-127.
4. Cohen I, Navarro V, Clemenceau S, Baulac M, and Miles R (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science (Wash DC) 298:1418-1421.
5. Colasanti BK, Lindamood C 3rd, and Craig CR (1982) Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav 16:573-578.
6. Consroe PF, Wood GC, and Buchsbaum H (1975) Anticonvulsant nature of marihuana smoking. J Am Med Assoc 234:306-307.
7. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, and Ko D (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029-1035.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
9. 2 receptor-mediated actions of anandamide in mouse brain. J Neurochem 75:2434-2444.
10. Hampson RE, Evans GJ, Mu J, Zhuang SY, King VC, Childers SR, and Deadwyler SA (1995) Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation ofpotassium "A-current" in cultured rat hippocampal neurons. Life Sci 56:2081-2088.
11. Hauser WA and Hesdorffer DC (1990) Epilepsy: Frequency, Causes and Consequences. Demos, New York.
12. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, and Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
13. House of Lords Select Committee on Science and Technology (1998) Cannabis: The Scientific and Medical Evidence, chapter 5, section 5.3, London. Available at: http://www.publications.parliament.uk/pa/ld199798/ldselect/ldsctech/151/15106. htm
14. 1 cannabinoid receptor induction in experimental stroke. Ann Neurol 48:257-261.
15. Karler R, Calder LD, and Turkanis SA (1986) Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol. Neuropharmacology 25:441-446.
16. Karler R, Cely W, and Turkanis SA (1974) Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids. Life Sci 15:931-947.
17. Karler R and Turkanis SA (1980) Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice. Br J Pharmacol 68:479-484.
18. Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Perez-Rosado A, Manzanares J, Ramos JA, and Fernandez-Ruiz J (2002) Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse 44:23-35.
19. Leite JP and Cavalheiro EA (1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20:93-104.
20. Lothman EW, Bertram EH, and Stringer JL (1991) Functional anatomy of hippocampal seizures. Prog Neurobiol 37:1-82.
21. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
22. Mackie K, Lai Y, Westenbroek R, and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
23. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
24. Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, and Finch DM (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34:985-995.
25. Morris TA, Jafari N, and DeLorenzo RJ (2001) Chronic delta FosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy. Brain Res Mol Brain Res 79:138-149.
26. National Institutes of Health (1997) Workshop on the Medical Utility of Marijuana, Report to the Director, Washington, D.C. Available at: http://www.nih.gov/news/medmarijuana/MedicalMarijuana.htm
27. Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, and Kano M (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22:3864-3872.
28. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, and Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature (Lond) 413:527-531.
29. Perlin JB, Gerwin CM, Panchision DM, Vick RS, Jakoi ER, and DeLorenzo RJ (1993) Kindling produces long-lasting and selective changes in gene expression of hippocampal neurons. Proc Natl Acad Sci USA 90:1741-1745.
30. Pettit DA, Harrison MP, Olson JM, Spencer RF, and Cabral GA (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 51:391-402.
31. R. v. Parker (1997), 12 C.R. (5th) 251 (Ont. Ct. Justice).
32. Raza M, Pal S, Rafiq A, and DeLorenzo RJ (2001) Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy. Brain Res 903:1-12.
33. Rice AC and DeLorenzo RJ (1998) NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 782:240-247.
34. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature (Lond) 414:209-212.
35. Stella N, Schweitzer P, and Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature (Lond) 388:773-778.
36. Sugiura T, Yoshinaga N, Kondo S, Waku K, and Ishima Y (2000) Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem Biophys Res Commun 271:654-658.
37. Wada JA, Wake A, Sato M, and Corcoran ME (1975) Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats. Epilepsia 16:503-510.
38. Wallace MJ, Martin BR, and DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452:295-301.
39. 1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428:51-57.
40. Wilson RI and Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (Lond) 410:588-592.